NCT01112397View on ClinicalTrials.gov

Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours

PHASE1TerminatedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Solid Malignancies

Interventions

DRUG

AZD1480

continuous daily oral capsule

Trial Locations (3)

Unknown

Research Site, Aurora

Research Site, Detroit

Research Site, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY